Dynamic Technology Lab Private LTD Syndax Pharmaceuticals Inc Transaction History

Dynamic Technology Lab Private LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$13.64 - $19.48 $353,453 - $504,785	-25,913 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$14.84 - $22.15 $384,548 - $573,972	25,913 New	25,913 $450,000
Q4 2017 Feb 09, 2018	SELL	$7.8 - $12.94 $102,242 - $169,617	-13,108 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$10.9 - $12.73 $142,877 - $166,864	13,108	13,108 $154,000

229

88.4M

1.01M

692K

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $742M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.